You have my permission to cheat on your screen time goal to read this article — you won't regret it when you see this ...

The new pressed powder pretty much contains the same ingredients as the fan-favorite loose powder — minus vitamin E, talc, and fragrance. They’re similar products, both intended to create a blurring ...

The European Medicines Agency has granted orphan drug status to LTI-03, an inhaled therapy being developed for people with ...

A global contract development and manufacturing organization focused on drug-device combination products. The company ...

Iconovo AB (publ.), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that it has agreed to conduct a feasibility study on behal ...

Bespak are a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery devices and ...

About Kinaset Therapeutics, Inc. Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. With founding investors 5AM ...

On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with US based biotech AirNexis. Under the agreement, ...

EQT Life Sciences is pleased to announce that the LSP 7 Fund has invested in Kinaset Therapeutics (the "Company"), a clinical-stage biopharmaceutical company based in Boston, U.S. developing a novel ...

This form of rapid-acting inhaled insulin, recently introduced in India by the name Afrezza, is said to offer an important ...

Proceeds to advance frevecitinib, an inhaled pan-JAK inhibitor with the potential to treat the broad severe asthma population, through Phase 2 studies ...